Theradex Oncology Awarded NCI Contract for Clinical Trial Monitoring Services

March 2023

Theradex Oncology was awarded the NCI contract and will continue to operate the Clinical Trial Monitoring Service (CTMS). Theradex has been an integral part of clinical trial management for the Early Phase Clinical Trial Network (ETCTN). Theradex Oncology continues to collaborate on early phase and randomized trials to support continued development of oncology.